AXA stock trades steady as 2025 earnings and solvency metrics underpin valuation

AXA SA (ISIN FR0000120620) stands out among European insurers as AXA stock continues to be underpinned by strong capital metrics and growing earnings, with its latest full-year figures highlighting how solvency and profitability interact in the current rate and claims environment.

Underlying earnings above EUR 7 billion

In its most recent annual reporting cycle, AXA announced underlying earnings of around EUR 7.5 billion for fiscal 2024, reflecting the insurer's ability to generate fee and underwriting income across its core health, property and casualty, and life businesses even as markets adjust to higher-for-longer interest rates and evolving claims trends.

That figure compares with approximately EUR 7.2 billion of underlying earnings recorded in fiscal 2023, implying earnings growth of roughly 4% year on year and signaling that AXA was able to offset headwinds from inflation and natural catastrophe costs with portfolio repricing, cost discipline, and a favorable yield backdrop on its investment portfolio.

Solvency ratio near one hundred eighty percent

Beyond earnings, AXA's capital position remains a critical anchor for investors assessing AXA stock, with the insurer's Solvency II ratio most recently reported in the region of 180% as of the end of fiscal 2024, comfortably above the internal target range often cited around 170% and offering scope for both shareholder distributions and reinvestment in growth initiatives.

Compared with a solvency ratio closer to 190% reported after fiscal 2023, the modest decline reflects capital deployment for dividends and share buybacks as well as model and market movements, yet still leaves AXA with a considerable buffer versus regulatory requirements and many peers in the European insurance space.

For equity holders, this solvency profile is significant, because it shapes expectations for future cash returns: at a level around 180%, AXA can sustain attractive dividends while also retaining flexibility to support acquisitions or organic investments in health, protection, and commercial lines.

Dividend policy and cash generation

Dividend capacity is another pillar that influences AXA stock valuation. In its latest cycle, AXA proposed an ordinary dividend of around EUR 1.98 per share for fiscal 2024, up from roughly EUR 1.70 per share for fiscal 2023, representing an increase of about 16% and aligning with the growth in underlying earnings and capital generation capacity.

In euro terms, the total dividend outlay approaches EUR 4.5 billion for fiscal 2024 when multiplied across the share count, demonstrating how AXA's recurring cash flow from underwriting and asset management operations translates into tangible returns for shareholders and signaling management confidence in the sustainability of its earnings base.

Alongside cash dividends, AXA has in recent years complemented distributions with occasional share repurchases, using its robust solvency ratio to manage the mix between returning capital and funding investments in growth, though exact buyback volumes vary by year in line with market conditions, regulatory dialogues, and strategic priorities.

Revenue growth and business mix

Revenue trends also matter for AXA stock. On a gross written premiums and other revenues basis, AXA generated total revenues of about EUR 100 billion in fiscal 2024 across its main segments, representing an increase compared with roughly EUR 97 billion in fiscal 2023 and underscoring that the insurer continues to expand its top line while refining its risk selection.

Health insurance has been one of AXA's growth engines, with health revenues estimated around EUR 18 billion in fiscal 2024 versus roughly EUR 16 billion in fiscal 2023, implying growth on the order of 12% and reflecting both higher volumes and pricing adjustments as AXA leverages its brand and distribution capabilities in key European and international markets.

In property and casualty, premium volumes have been supported by commercial lines and personal motor and household portfolios, where rate increases designed to keep pace with claims inflation contributed to revenue growth. At the same time, AXA has sought to maintain underwriting discipline by exiting less attractive niches and focusing on lines with resilient demand and manageable volatility.

Operating margins and claims environment

Margins are central in the insurance industry, and AXA's operating performance has benefited from both higher investment income and careful management of its claims environment. The insurer's combined ratio in property and casualty – a key measure of underwriting profitability – was reported around 93% for fiscal 2024, an improvement from roughly 95% in fiscal 2023, signaling that underwriting remained profitable before investment returns.

This two-point improvement in combined ratio reflects actions taken in pricing, risk selection, and claims management, including targeted rate increases and portfolio adjustments in segments where loss experience had previously eroded margins. Lower natural catastrophe burdens relative to prior peaks also helped the ratio in the latest year.

In the life and savings segment, AXA has continued to pivot toward capital-light products that carry lower balance-sheet risk and more stable fee income. This strategic shift supports profitability by reducing the sensitivity of earnings to long-term guarantees and interest-rate movements, while freeing capital that can be redeployed in higher-return activities or used to underpin shareholder distributions.

Interest rates, investment income, and asset allocation

The interest-rate environment has been a key macro factor supporting AXA stock. Higher yields compared with the ultra-low era have raised investment income on the insurer's bond portfolio, benefiting the net investment result across both life and property and casualty operations. For 2024, AXA's net investment income is estimated in the double-digit billion euro range, reflecting the scale of its asset base.

AXA actively manages asset allocation to balance yield with risk, holding a mix of government bonds, investment-grade corporate debt, equities, real estate, and alternative assets. The aim is to generate stable income that can support claims payments and policyholder obligations while also contributing to earnings and capital growth.

As yields evolve, AXA must navigate the impact on both the asset side and liability discounts. However, the insurer's focus on capital-light offerings and disciplined asset-liability management helps mitigate interest-rate risk, reducing potential volatility in its solvency ratio and underlying earnings.

ESG considerations and strategic priorities

Environmental, social, and governance (ESG) considerations have grown in importance for European insurers, and AXA has articulated ambitions to align its investment and underwriting portfolios with climate-transition objectives. This includes commitments to reduce exposure to certain fossil-fuel activities over time and to increase financing for sustainable projects, though the pace and exact metrics vary across regions and product lines.

From a strategic perspective, AXA continues to prioritize growth in health insurance, protection products, and commercial lines where demand is structurally supported by demographics, corporate risk awareness, and regulatory frameworks. Investments in digital distribution and claims processing aim to enhance efficiency, customer experience, and data-driven risk selection.

For AXA stock, these strategic choices are relevant because they shape the sustainability of earnings and the insurer's ability to maintain attractive margins and dividend capacity in a competitive marketplace where customers increasingly value both financial security and ESG alignment.

AXA XL and specialty insurance

AXA's AXA XL division, focused on large commercial and specialty risks, plays a key role in the group's earnings mix. Specialty lines such as cyber, marine, aviation, and financial lines can offer higher margins but also carry greater volatility, prompting AXA to refine underwriting approaches and reinsurance structures to balance risk and reward.

Recent years have seen AXA adjust its exposure to certain catastrophe-prone segments and refine its use of reinsurance to manage tail risk. As a result, AXA XL has been positioned as a contributor to group earnings while aiming to avoid disproportionate earnings volatility from single large events.

For investors, AXA XL matters because its performance can materially influence the group's combined ratio and capital requirements. Strong results in specialty lines can support overall earnings growth, while adverse years can test capital and risk-management frameworks, making the division's strategy and execution a recurring topic in investor discussions.

Product focus: health insurance and protection

One of AXA's representative product areas is health insurance and broader protection solutions, which have become a central pillar of the business model. Health revenues around EUR 18 billion in fiscal 2024 underscore how this segment has grown as customers seek comprehensive coverage for medical expenses and preventive care, often linked with employer-sponsored schemes or individual policies.

AXA's health offerings range from basic coverage to more comprehensive plans, often bundled with digital services such as telemedicine, wellness apps, and data-driven preventive programs. These products aim to improve health outcomes while managing claims costs through early intervention and care coordination.

Protection products – including life insurance, disability coverage, and income protection – complement health offerings by addressing longer-term risks. As populations age and social-security systems face pressure, demand for private protection mechanisms remains resilient, providing AXA with a steady business base that supports its recurring earnings profile.

AXA stock and market valuation

On the equity market, AXA stock is listed on Euronext Paris and forms part of the CAC 40 index, underscoring its status as a core French blue chip and a significant component of European insurance exposure in many portfolios. As of a recent trading session in 2026, AXA shares traded around EUR 30 on Euronext Paris, implying an equity market capitalization in the region of EUR 70 billion based on the outstanding share count.

At that price level, AXA stock trades on a price-to-earnings multiple in the single-digit to low double-digit range when measured against underlying earnings around EUR 7.5 billion, suggesting that investors continue to weigh factors such as cyclical claims risk, regulatory developments, and macro uncertainties alongside the insurer's strong solvency and dividend profile.

For holders and prospective investors, the interaction between AXA's solvency ratio near 180%, rising underlying earnings, and dividend capacity near EUR 1.98 per share frames the debate about valuation: the market must decide how much it is willing to pay for a capital-strong, cash-generative insurer amid shifting macro and regulatory conditions.